# An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

> **NCT06010472** · EARLY_PHASE1 · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DRUG:** anti-CD19 CAR NK cells (KN5501)

## Key facts

- **NCT ID:** NCT06010472
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-20
- **Primary completion:** 2026-08-25
- **Final completion:** 2027-08-25
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06010472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06010472, "An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06010472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*